CHLA Clinical Research Studies

Having volunteers participate in research studies and clinical trials is critical to our research efforts. Thousands of children and families are involved in our patient-centered studies every year. Many of the treatments used today are based on the results of past research studies and clinical trials conducted with our patients. Our scientific and clinical experts take the best ideas from the laboratory -- to the patient -- in the form of promising new treatments.

By searching our study directory, you may identify research that could impact the life of your child or of another child you know. Because the number of available research studies and clinical trials for children nationwide is small, every participant makes a significant contribution.

In addition to enrolling children with certain diseases in order to study treatments and prevention of those diseases, we also need to study healthy children. Ask your child’s doctor about volunteer study options that may be suitable for your child.

Please contact the study staff listed in your search results for more information.

Search by Keyword:    

Back to the full listing

Study Details - ID: CHLA-20-00228
Health/Science/Disease Category:
Iron Deficiency Anemia
Short Name:
Cerebrovascular Impact of Acquired Anemias
Full Title of Study:
Cerebrovascular Impact of Acquired Anemias
Phase/Type of Study:
observational
Purpose of Research:
The objective of this study is to learn how anemia may affect oxygen delivery to the brain as measured by magnetic resonance imaging (MRI). By studying this, we hope to better identify people who may benefit from correction of their anemia
Eligibility:
Males and females between 16 and 60 years old, have moderate to severe anemia (hemoglobin less than or equal to 10.5g/dl; or hematocrit less than 32%), and are able to undergo MRI scan for about 1.5 hours without needing sedation
Time Commitment/Requirements:
Participants will be scheduled for 1 MRI visit and 1 neurocognitive test visit, each lasting for about 3 hours.
Primary Investigator:
Dr. John C. Wood, MD, PhD
Coordinator Contact Name:
Silvie Suriany
Phone Number:
323-361-4783
Email:
ssuriany@chla.usc.edu
Clinical Trials .Gov Identifier:
NA